These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 32199148
1. Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry. Luirink IK, Hutten BA, Greber-Platzer S, Kolovou GD, Dann EJ, de Ferranti SD, Taylan C, Bruckert E, Saheb S, Oh J, Driemeyer J, Farnier M, Pape L, Schmitt CP, Novoa FJ, Maeser M, Masana L, Shahrani A, Wiegman A, Groothoff JW. Atherosclerosis; 2020 Apr; 299():24-31. PubMed ID: 32199148 [Abstract] [Full Text] [Related]
2. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry). Kayikcioglu M, Tokgozoglu L, Yilmaz M, Kaynar L, Aktan M, Durmuş RB, Gokce C, Temizhan A, Ozcebe OI, Akyol TK, Okutan H, Sag S, Gul OO, Salcioglu Z, Yenercag M, Altunkeser BB, Kuku I, Yasar HY, Kurtoglu E, Kose MD, Demircioglu S, Pekkolay Z, Ilhan O. Atherosclerosis; 2018 Mar; 270():42-48. PubMed ID: 29407887 [Abstract] [Full Text] [Related]
3. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries. Reijman MD, Tromp TR, Hutten BA, Hovingh GK, Blom DJ, Catapano AL, Cuchel M, Dann EJ, Gallo A, Hudgins LC, Raal FJ, Ray KK, Sadiq F, Soran H, Groothoff JW, Wiegman A, Kusters DM, Homozygous Familial Hypercholesterolaemia International Clinical Collaborators (HICC), Children with Homozygous Hypercholesterolemia on Lipoprotein Apheresis: an International Registry (CHAIN) consortia. Lancet Child Adolesc Health; 2024 Jul; 8(7):491-499. PubMed ID: 38759658 [Abstract] [Full Text] [Related]
4. Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017. Pottle A, Thompson G, Barbir M, Bayly G, Cegla J, Cramb R, Dawson T, Eatough R, Kale V, Neuwirth C, Nicholson K, Payne J, Scott J, Soran H, Walji S, Watkins S, Weedon H, Nath Datta DB. Atherosclerosis; 2019 Nov; 290():44-51. PubMed ID: 31563836 [Abstract] [Full Text] [Related]
5. High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption. Drouin-Chartier JP, Tremblay AJ, Bergeron J, Lamarche B, Couture P. Atherosclerosis; 2018 Mar; 270():26-32. PubMed ID: 29407885 [Abstract] [Full Text] [Related]
6. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)? Kayikcioglu M, Tokgozoglu L, Dogan V, Ceyhan C, Tuncez A, Kutlu M, Onrat E, Alici G, Akbulut M, Celik A, Yesilbursa D, Sahin T, Sonmez A, Ozdogan O, Temizhan A, Kilic S, Bayram F, Sabuncu T, Coskun FY, Ildizli M, Durakoglugil E, Kirilmaz B, Yilmaz MB, Yigit Z, Yildirim AB, Gedikli O, Topcu S, Oğuz A, Demir M, Yenerçağ M, Yıldırır A, Demircan S, Yilmaz M, Kaynar LG, Aktan M, Durmus RB, Gokce C, Ozcebe Oİ, Akyol TK, Okutan H, Sag S, Gul OO, Salcioglu Z, Altunkeser BB, Kuku I, Yasar HY, Kurtoglu E, Kose MD, Demircioglu S, Pekkolay Z, Ilhan O, Can LH. Atherosclerosis; 2018 Oct; 277():341-346. PubMed ID: 30270069 [Abstract] [Full Text] [Related]
8. Homozygous familial hypercholesterolemia with severe involvement of the aortic valve-A sibling-controlled case study on the efficacy of lipoprotein apheresis. Galiano M, Hammersen J, Sauerstein K, Blessing H, Rümmele P, Purbojo A, Schöber M, Moosmann J, Raffelsbauer G, Heibges A, Klingel R. J Clin Apher; 2020 Jun; 35(3):163-171. PubMed ID: 32163632 [Abstract] [Full Text] [Related]
9. Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France. Bruckert E, Kalmykova O, Bittar R, Carreau V, Béliard S, Saheb S, Rosenbaum D, Bonnefont-Rousselot D, Thomas D, Emery C, Khoshnood B, Carrié A. Atherosclerosis; 2017 Feb; 257():130-137. PubMed ID: 28131047 [Abstract] [Full Text] [Related]
10. Treatment of homozygous familial hypercholesterolaemia in paediatric patients: A monocentric experience. Buonuomo PS, Macchiaiolo M, Leone G, Valente P, Mastrogiorgio G, Gnazzo M, Rana I, Gonfiantini MV, Gagliardi MG, Romano F, Bartuli A. Eur J Prev Cardiol; 2018 Jul; 25(10):1098-1105. PubMed ID: 29785886 [Abstract] [Full Text] [Related]
11. Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry). Kayikcioglu M, Kuman-Tunçel O, Pirildar S, Yílmaz M, Kaynar L, Aktan M, Durmuş RB, Gökçe C, Temizhan A, Özcebe OI, Akyol TK, Okutan H, Sağ S, Oz Gul O, Salcioglu Z, Yenercag M, Altunkeser BB, Kuku I, Yasar HY, Kurtoğlu E, Demir M, Demircioğlu S, Pekkolay Z, Ílhan O, Tokgozoglu L. J Clin Lipidol; 2019 Jul; 13(3):455-467. PubMed ID: 30928440 [Abstract] [Full Text] [Related]
12. Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia. Béliard S, Saheb S, Litzler-Renault S, Vimont A, Valero R, Bruckert É, Farnier M, Gallo A. Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1447-1454. PubMed ID: 38695169 [Abstract] [Full Text] [Related]
13. Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review. Luirink IK, Determeijer J, Hutten BA, Wiegman A, Bruckert E, Schmitt CP, Groothoff JW. J Clin Lipidol; 2019 Jun; 13(1):31-39. PubMed ID: 30553758 [Abstract] [Full Text] [Related]
14. Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica. Alves AC, Alonso R, Diaz-Diaz JL, Medeiros AM, Jannes CE, Merchan A, Vasques-Cardenas NA, Cuevas A, Chacra AP, Krieger JE, Arroyo R, Arrieta F, Schreier L, Corral P, Bañares VG, Araujo MB, Bustos P, Asenjo S, Stoll M, Dell'Oca N, Reyes M, Ressia A, Campo R, Magaña-Torres MT, Metha R, Aguilar-Salinas CA, Ceballos-Macias JJ, Morales ÁJR, Mata P, Bourbon M, Santos RD. Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2508-2515. PubMed ID: 32757650 [Abstract] [Full Text] [Related]
15. Lipoprotein-apheresis in familial hypercholesterolemia: Long-term patient compliance in a French cohort. Beliard S, Gallo A, Duchêne E, Carrié A, Bittar R, Chapman MJ, Bruckert E, Saheb S. Atherosclerosis; 2018 Oct; 277():66-71. PubMed ID: 30176566 [Abstract] [Full Text] [Related]
16. Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre. Mickiewicz A, Borowiec-Wolna J, Bachorski W, Gilis-Malinowska N, Gałąska R, Raczak G, Chmara M, Wasąg B, Jaguszewski MJ, Fijałkowski M, Gruchała M. Cardiol J; 2019 Oct; 26(6):669-679. PubMed ID: 30234904 [Abstract] [Full Text] [Related]
17. The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis. Leipold R, Raal F, Ishak J, Hovingh K, Phillips H. Eur J Prev Cardiol; 2017 Nov; 24(17):1843-1850. PubMed ID: 28925748 [Abstract] [Full Text] [Related]